Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$8.58 |
52 Week High | US$10.96 |
52 Week Low | US$8.41 |
Beta | 0 |
1 Month Change | -4.51% |
3 Month Change | -8.82% |
1 Year Change | -18.80% |
3 Year Change | -18.51% |
5 Year Change | -0.20% |
Change since IPO | 6.66% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
BIOT | NL Capital Markets | NL Market | |
---|---|---|---|
7D | -1.1% | -1.0% | -4.3% |
1Y | -18.8% | 7.7% | 13.8% |
Return vs Industry: BIOT underperformed the Dutch Capital Markets industry which returned 7.7% over the past year.
Return vs Market: BIOT underperformed the Dutch Market which returned 13.8% over the past year.
Price Volatility
BIOT volatility | |
---|---|
BIOT Average Weekly Movement | 1.9% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 3.7% |
10% most volatile stocks in NL Market | 7.5% |
10% least volatile stocks in NL Market | 2.2% |
Stable Share Price: BIOT has not had significant price volatility in the past 3 months.
Volatility Over Time: BIOT's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | fundcentres.lgim.com/uk/private/fund-centre/ETF/Pharma-Breakthrough |
Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF Fundamentals Summary
BIOT fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs BIOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIOT income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did BIOT perform over the long term?
See historical performance and comparison